3 results
The primary objectives of the Phase Ib portion of the study are as follows:* To assess the safety and tolerability of the combination of polatuzumab vedotin with bendamustine and rituximab (BR) or bendamustine and obinutuzumab (BG) when administered…
The aim of the study is to document changes in CTO vessels physiology post PCI and at 3 months follow up. We intend to look for correlations between anatomical features identified with intravascular imaging and physiological parameters, how these…
To describe the between- and within-subject variability of mitoPO2 measurements during a 24 hour period after 5- aminolevulinic acid (ALA)-induction among healthy volunteers and among neurosurgical patients admitted postoperatively to the ICU, MC,…